Standardized Indices of Breathlessness

标准化呼吸困难指数

基本信息

  • 批准号:
    7283602
  • 负责人:
  • 金额:
    $ 44.42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-03-01 至 2008-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): For patients with respiratory disease the symptom of breathlessness (dyspnea) is the most frequent reason for seeking medical attention. Current methods for measuring the impact of breathlessness on activities of daily living rely on face-to-face interviews conducted by health care providers. Two common measures are the Baseline Dyspnea Index representing the severity of dyspnea at a single point in time, and the Transition Dyspnea Index representing changes in dyspnea compared with the baseline level before treatment. Despite widespread acceptance of these measures, the interview technique has been criticized on three counts: (1) selection of severity of breathlessness is made by the interviewer, not the patient, and thereby can increase measurement error (2) the method cannot be applied consistently in different medical centers because the same interviewers are not employed at all test sites (3) the process is expensive due to the cost of training and employing health care providers to conduct interviews and enter data into the computer. There is a need for a less expensive, standardized approach to the measurement of dyspnea that could be applied consistently throughout the world. In Phase I of this project computerized versions of the Baseline Dyspnea Index and the Transitional Dyspnea Index were developed and tested for concurrent validity by comparison with interview versions, and for construct validity by comparison with pulmonary function tests. The aims of Phase II are to determine further psychometric and clinical properties of the standardized methods: test- retest reliability of both the Baseline and Transition Dyspnea Indices, responsiveness and the minimally important clinical difference of the Transition Dyspnea Index. Subjects employing the new, standardized computer methods will be 126 patients diagnosed with chronic lung disease. PROPOSED COMMERCIAL APPLICATIONS. There are excellent commercial prospects for computer software that allows the patient to rate their level of dyspnea associated with activities of daily living. Once the software package is implemented and tested, site licenses for acquiring the program will be sold to clinics, hospitals, and pharmaceutical companies worldwide. The computer assessment instruments developed in this project will quantify the patient-reported outcomes of lung disease. The overall goal is to further our understanding about these diseases and to identify better clinical outcome measures.
描述(由申请人提供):呼吸困难(呼吸困难)是呼吸系统疾病患者求医最常见的症状。目前测量呼吸困难对日常生活活动影响的方法依赖于卫生保健提供者进行的面对面访谈。两种常用的测量方法是基线呼吸困难指数(Baseline Dyspnea Index)和过渡呼吸困难指数(Transition Dyspnea Index),前者表示单个时间点呼吸困难的严重程度,后者表示与治疗前基线水平相比呼吸困难的变化。尽管这些措施被广泛接受,但面试技巧在三个方面受到了批评:(1)呼吸困难程度的选择是由采访者而不是患者做出的,因此可能会增加测量误差(2)该方法不能在不同的医疗中心一致地应用,因为并非所有的测试地点都雇用相同的采访者(3)由于培训和雇用卫生保健提供者进行访谈并将数据输入计算机的成本,该过程是昂贵的。需要一种更便宜、标准化的方法来测量呼吸困难,这种方法可以在世界范围内一致应用。在该项目的第一阶段,开发了基线呼吸困难指数和过渡性呼吸困难指数的计算机版本,并通过与访谈版本的比较测试了并发效度,并通过与肺功能测试的比较测试了结构效度。第二阶段的目的是进一步确定标准化方法的心理测量学和临床特性:基线和过渡期呼吸困难指数的测试-再测试信度、反应性和过渡期呼吸困难指数的最小重要临床差异。采用新的标准化计算机方法的受试者将是126名诊断为慢性肺病的患者。建议的商业应用。计算机软件有很好的商业前景,它可以让病人评估与日常生活活动相关的呼吸困难程度。一旦软件包实现并经过测试,获取该程序的站点许可证将出售给世界各地的诊所、医院和制药公司。本项目开发的计算机评估工具将量化患者报告的肺部疾病结果。总体目标是进一步加深我们对这些疾病的了解,并确定更好的临床结果指标。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN C BAIRD其他文献

JOHN C BAIRD的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN C BAIRD', 18)}}的其他基金

Three-Dimensional Pain Mapping
三维疼痛图
  • 批准号:
    7600742
  • 财政年份:
    2009
  • 资助金额:
    $ 44.42万
  • 项目类别:
Children's Computer Assessment of Pain and Mood
儿童疼痛和情绪的计算机评估
  • 批准号:
    7896624
  • 财政年份:
    2006
  • 资助金额:
    $ 44.42万
  • 项目类别:
Children's Computer Assessment of Pain
儿童计算机疼痛评估
  • 批准号:
    7157950
  • 财政年份:
    2006
  • 资助金额:
    $ 44.42万
  • 项目类别:
Standardized Indices of Breathlessness
标准化呼吸困难指数
  • 批准号:
    6879362
  • 财政年份:
    2005
  • 资助金额:
    $ 44.42万
  • 项目类别:
Standardized Indices of Breathlessness
标准化呼吸困难指数
  • 批准号:
    7158099
  • 财政年份:
    2004
  • 资助金额:
    $ 44.42万
  • 项目类别:
Dynamic Assessment of Hearing Aids
助听器的动态评估
  • 批准号:
    7108104
  • 财政年份:
    2002
  • 资助金额:
    $ 44.42万
  • 项目类别:
Dynamic Assessment of Hearing Aids
助听器的动态评估
  • 批准号:
    7204180
  • 财政年份:
    2002
  • 资助金额:
    $ 44.42万
  • 项目类别:
Dynamic Assessment of Hearing Aids
助听器的动态评估
  • 批准号:
    6551439
  • 财政年份:
    2002
  • 资助金额:
    $ 44.42万
  • 项目类别:
Continuous Measurement of Breathlessness
连续测量呼吸困难
  • 批准号:
    6585727
  • 财政年份:
    2001
  • 资助金额:
    $ 44.42万
  • 项目类别:
Computer Assessment of Pain
计算机疼痛评估
  • 批准号:
    6949710
  • 财政年份:
    2001
  • 资助金额:
    $ 44.42万
  • 项目类别:

相似海外基金

Defining new asthma phenotypes using high-dimensional data
使用高维数据定义新的哮喘表型
  • 批准号:
    2901112
  • 财政年份:
    2024
  • 资助金额:
    $ 44.42万
  • 项目类别:
    Studentship
Air pollution and Asthma in Canada: Projections of burden and the value of climate adaptation strategies
加拿大的空气污染和哮喘:负担预测和气候适应战略的价值
  • 批准号:
    485322
  • 财政年份:
    2023
  • 资助金额:
    $ 44.42万
  • 项目类别:
    Operating Grants
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
  • 批准号:
    493135
  • 财政年份:
    2023
  • 资助金额:
    $ 44.42万
  • 项目类别:
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
患有自身免疫性疾病和哮喘的孕妇及其子女的生物药物安全性和有效性国际药物流行病学研究(BIONIC)
  • 批准号:
    493526
  • 财政年份:
    2023
  • 资助金额:
    $ 44.42万
  • 项目类别:
    Operating Grants
Engaging Patient and Caregivers in Using Patient-reported Outcomes Measures in Pediatric Clinical Care for Asthma
让患者和护理人员参与儿科哮喘儿科临床护理中患者报告的结果测量
  • 批准号:
    495593
  • 财政年份:
    2023
  • 资助金额:
    $ 44.42万
  • 项目类别:
Basophilic oncostatin M fuels nociceptor neuron-induced asthma
嗜碱性制瘤素 M 促进伤害感受器神经元诱发哮喘
  • 批准号:
    485504
  • 财政年份:
    2023
  • 资助金额:
    $ 44.42万
  • 项目类别:
    Salary Programs
Mechanistic Study of Inspiratory Training in Childhood Asthma
儿童哮喘吸气训练机制研究
  • 批准号:
    10637048
  • 财政年份:
    2023
  • 资助金额:
    $ 44.42万
  • 项目类别:
Early life exposure to metal mixtures: impacts on asthma and lungdevelopment
生命早期接触金属混合物:对哮喘和肺部发育的影响
  • 批准号:
    10678307
  • 财政年份:
    2023
  • 资助金额:
    $ 44.42万
  • 项目类别:
Lung resident Treg suppression of Th2 resident memory T cells in allergic asthma
过敏性哮喘中肺常驻 Treg 对 Th2 常驻记忆 T 细胞的抑制
  • 批准号:
    10664599
  • 财政年份:
    2023
  • 资助金额:
    $ 44.42万
  • 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
  • 批准号:
    10813753
  • 财政年份:
    2023
  • 资助金额:
    $ 44.42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了